Home > Newsletters > International Pharmaceutical Regulatory Monitor > Value-Based Pricing: UK Set to Begin Negotiations on New Brand Drugs Scheme
International Pharmaceutical Regulatory Monitor
August 2012 | Vol. 40 No. 8
Value-Based Pricing: UK Set to Begin Negotiations on New Brand Drugs Scheme
Negotiations on the future of UK pricing and reimbursement policies for brand drugs will begin in September, according to a joint statement by the Department of Health and the Association of the British Pharmaceutical Industry (ABPI).
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.